Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LARGE
NCT00200967Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2004
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salmeterol in asthma (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Morning Peak Expiratory Flow Rate at 18 weeks. Started Dec 2004; status: completed.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00200967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200967.